Targeted Genomics LLC Announces Business Partnership with OraSure Technologies

Summary

Targeted Genomics LLC, the developer of GlutenID, the first and only FDA-approved direct-to-consumer genetic test for celiac disease, announced a commercial cooperation with Orasure Technologies.Benzinga

Impact Analysis

The collaboration between Targeted Genomics LLC and Orasure Technologies can lead to several direct impacts on both companies. First-order effects include potential growth in market share for Targeted Genomics due to enhanced distribution capabilities or technological support from Orasure. This partnership may also introduce operational efficiencies and innovation opportunities through shared resources and expertise. However, potential risks involve dependency on Orasure’s technologies or market trends affecting both companies. Second-order effects could involve increased competition in the genetic testing industry, pressuring peer companies to form similar alliances. Investment opportunities may include evaluating options strategies focused on capturing potential upside from expanded market reach or mitigating risks related to industry volatility.Benzinga